JAK2 and essential thrombocythemia: However, erythroblasts harbouring the JAK2 exon 12 mutations which drive erythrocytosis and are only associated with PV have a transcriptional profile which cannot be distinguished from JAK2 V617F positive ET erythroblasts with no differential in STAT1 activation [64].